Messaging Strategies for Vaping

Overseen By Donghee N Lee, PhD

Age: 18 - 65

Sex: Any

Trial Phase: Academic

Sponsor: University of Massachusetts, Worcester

Disqualifiers: Age, English fluency, Platform membership

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

Duration: 20 minutes

800 Participants Needed

Trial Summary

What is the purpose of this trial?

The goal of this clinical trial is to use crowdsourcing to test the effects of a message source (expert and peer) and message presentation types (one-sided and two-sided) to identify the optimal message type for young adults who vape and do not vape.

Research Team

Donghee N Lee, PhD

Principal Investigator

UMass Chan Medical School

Eligibility Criteria

This trial is for US residents aged 18-24 who speak English fluently. Participants must have either used e-cigarettes in the past month or not used them but are open to trying. It's aimed at understanding how young adults respond to different vaping messages.

Inclusion Criteria

I am a US resident aged between 18 and 24.

Reporting either vaping in the past 30 days or susceptible to vaping

Fluent in English

Exclusion Criteria

I am not fluent in English.

Not a member of partnering crowdsourcing behavioral research platform conducting the study

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive e-cigarette education messages manipulated in sidedness and source types

20 minutes

1 visit (virtual)

Follow-up

Participants are monitored for responses to e-cigarette education messages

1-2 weeks

Treatment Details

Interventions

• E-cigarette Message Source and Presentation

Trial Overview The study is examining how effective various message sources (expert vs peer) and styles (one-sided vs two-sided arguments) are on influencing young adults' views on vaping, whether they currently vape or might consider it.

Participant Groups

Group I: Source Experimental Treatment 2 Interventions

Participants in source arm will receive e-cigarette education messages manipulated in one of two source types.

Group II: Sidedness Experimental Treatment 2 Interventions

Participants in sidedness arm will receive e-cigarette education messages manipulated in one of two sidedness types.

Who Is Running the Clinical Trial?

University of Massachusetts, Worcester

Lead Sponsor

Trials

372

Recruited

998,000+

National Cancer Institute (NCI)

Collaborator

Trials

14,080

Recruited

41,180,000+